These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 12777317)
1. Fibrinolysis for acute myocardial infarction: the future is here and now. Armstrong PW; Collen D; Antman E Circulation; 2003 May; 107(20):2533-7. PubMed ID: 12777317 [No Abstract] [Full Text] [Related]
2. Fibrinolytic therapy: is it a treatment of the past? Grines CL; Serruys P; O'Neill WW Circulation; 2003 May; 107(20):2538-42. PubMed ID: 12777318 [No Abstract] [Full Text] [Related]
4. Pharmacological reperfusion in acute myocardial infarction after ASSENT 3 and GUSTO V. Ferreira D Rev Port Cardiol; 2003; 22(7-8):1005-9. PubMed ID: 14587168 [No Abstract] [Full Text] [Related]
5. [Strategies to improve reperfusion with fibrinolytic therapy in ST-T elevation myocardial infarction]. Jerjes-Sánchez C; Sosa del Angel E; García Sosa A; Reyes Cerezo E; Garza Ruiz A Arch Cardiol Mex; 2003; 73(1):46-58. PubMed ID: 12820494 [TBL] [Abstract][Full Text] [Related]
6. Overview of contemporary reperfusion strategies in acute ST-elevation myocardial infarction. Haude M; Schulz R; Heusch G; Erbel R Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):667-80. PubMed ID: 16076277 [TBL] [Abstract][Full Text] [Related]
7. Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction. Antman EM; Van de Werf F Circulation; 2004 Jun; 109(21):2480-6. PubMed ID: 15173037 [No Abstract] [Full Text] [Related]
9. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25). Antman EM; Morrow DA; McCabe CH; Jiang F; White HD; Fox KA; Sharma D; Chew P; Braunwald E; Am Heart J; 2005 Feb; 149(2):217-26. PubMed ID: 15846258 [No Abstract] [Full Text] [Related]
10. Fibrinolytic agents for the management of ST-segment elevation myocardial infarction. Hilleman DE; Tsikouris JP; Seals AA; Marmur JD Pharmacotherapy; 2007 Nov; 27(11):1558-70. PubMed ID: 17963464 [TBL] [Abstract][Full Text] [Related]
11. Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options. Boden WE; Eagle K; Granger CB J Am Coll Cardiol; 2007 Sep; 50(10):917-29. PubMed ID: 17765117 [TBL] [Abstract][Full Text] [Related]
12. ExTRACT-TIMI 25 trial: clarifying the role of enoxaparin in patients with ST-elevation myocardial infarction receiving fibrinolysis. Gabriel RS; White HD Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):851-7. PubMed ID: 17867915 [TBL] [Abstract][Full Text] [Related]
13. Current status of antithrombotic agents in acute myocardial infarction. Khalilullah M; Sathyamurthy I J Assoc Physicians India; 1981 May; 29(5):351-7. PubMed ID: 7028713 [No Abstract] [Full Text] [Related]
14. [Reperfusion in acute ST-elevation infarction: Fibrinolysis prior to elective PCI impairs the result!]. Eriksson P Lakartidningen; 2006 Jul 12-25; 103(28-29):2126-7. PubMed ID: 16895094 [No Abstract] [Full Text] [Related]
15. A strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study. Scirica BM; Morrow DA; Sadowski Z; Ruda M; Nicolau JC; Giugliano RP; Wiviott SD; Sabatine MS; Shui A; Antman EM; Braunwald E Eur Heart J; 2007 Sep; 28(17):2070-6. PubMed ID: 17600039 [TBL] [Abstract][Full Text] [Related]
16. Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1. Armstrong PW; Collen D Circulation; 2001 Jun; 103(23):2862-6. PubMed ID: 11401946 [No Abstract] [Full Text] [Related]
17. [Bolus fibrinolysis in acute myocardial infarction]. Zeymer U Dtsch Med Wochenschr; 2002 Oct; 127(40):2083-6. PubMed ID: 12373644 [No Abstract] [Full Text] [Related]
18. [Anticoagulant therapy in acute myocardial infarct. Therapeutic indications based on incomplete experimental data]. Goldman L Recenti Prog Med; 1980 Apr; 68(4):382-93. PubMed ID: 6992245 [No Abstract] [Full Text] [Related]
19. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial. Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E; Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601 [TBL] [Abstract][Full Text] [Related]
20. Single lead ST-segment recovery: a simple, reliable measure of successful fibrinolysis after acute myocardial infarction. Syed MA; Borzak S; Asfour A; Gunda M; Obeidat O; Murphy SA; Gibbons RJ; Gourlay SG; Barron HV; Weaver WD; Hudson M Am Heart J; 2004 Feb; 147(2):275-80. PubMed ID: 14760325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]